Evaluation of serum platelet-derived growth factor receptor-ß and brain-derived neurotrophic factor levels in

Gamze Aslan1, Veli Polat2, Evin Bozcali1

  • 1Department of Cardiology, Faculty of Medicine, Koç University Hospital; İstanbul-Turkey.

Abstract

Insights

Microvascular angina (MVA) is linked to elevated levels of Platelet-Derived Growth Factor Receptor beta (PDGFR-β) and Brain-Derived Neurotrophic Factor (BDNF). These biomarkers may indicate impaired microvascular function in MVA patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomarker Research

Background:

  • Microvascular angina (MVA) is a condition affecting the heart's small blood vessels.
  • Dysfunction in microcirculation is central to MVA pathogenesis.
  • Platelet-derived growth factor receptor beta (PDGFR-β) and brain-derived neurotrophic factor (BDNF) are implicated in microcirculation and pericyte function.

Purpose of the Study:

  • To investigate the association between PDGFR-β, BDNF, and microvascular angina (MVA).
  • To explore the role of these biomarkers in the etiopathogenesis of MVA.

Main Methods:

  • Serum concentrations of PDGFR-β and BDNF were measured using enzyme-linked immunosorbent assay kits.
  • The study included 91 MVA patients and 61 control subjects.
  • Statistical analyses, including correlation and binary logistic regression, were performed.

Main Results:

  • Patients with MVA exhibited significantly higher serum concentrations of PDGFR-β and BDNF compared to controls.
  • PDGFR-β levels positively correlated with age, low-density lipoprotein, and BDNF.
  • PDGFR-β, high-sensitivity C-reactive protein, and uric acid were identified as independent predictors of MVA.

Conclusions:

  • MVA is associated with elevated levels of PDGFR-β and BDNF.
  • These findings suggest potential abnormalities in microvascular function in MVA.
  • Further research is needed to elucidate the precise role of PDGFR-β and BDNF in MVA pathogenesis.